Roche and Exiqon to Co-Market Products for qPCR-based MicroRNA Profiling

The co-marketing pact builds on a licensing agreement related to the same technologies that has been in place since at least 2005 and provides an entry point for Roche in the burgeoning miRNA field.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.